The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans
Abstract
Confirmed infection with HTLV-II (human T cell leukemia virus type II) has been described only in rare cases. The major limitation to serological diagnosis of HTLV-II has been the difficulty of distinguishing HTLV-II from HTLV-I (human T cell leukemia virus type I) infection, because of substantial cross-reactivity between the viruses. A sensitive modification of the polymerase chain reaction method was used to provide unambiguous molecular evidence that a significant proportion of intravenous drug abusers are infected with HTLV, and the majority of these individuals are infected with HTLV-II rather than HTLV-I. Of 23 individuals confirmed by polymerase chain reaction analysis to be infected with HTLV, 21 were identified to be infected with HTLV-II, and 2 were infected with HTLV-I. Molecular identification of an HTLV-II—infected population provides an opportunity to investigate the pathogenicity of HTLV-II in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
A new method for sequencing DNA.
Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,922
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Yoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169
Seiki, M., Hattori, S., Hirayama, Y., & Yoshida, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3618 · Cited by 1,525
Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6981847 · Cited by 1,196
Cited by
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Self-citationThe Polymerase Chain Reaction: A New Method of Using Molecular Genetics for Medical Diagnosis
Desforges, J. F., & Eisenstein, B. I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220307 · Cited by 1,158
Global epidemiology of HTLV-I infection and associated diseases
Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C., & Murphy, E. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208968 · Cited by 1,008
zur Hausen, H. (1991) · Science · doi:10.1126/science.1659743 · Cited by 784
O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., ldler, K., Zack, J. A., & Chen, I. S. Y. (1990) · Nature · doi:10.1038/348069a0 · Cited by 570
Self-citationRichman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
Zack, J. A., Haislip, A. M., Krogstad, P., & Chen, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1717-1725.1992 · Cited by 400
Self-citationPathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection
Flier, J. S., Underhill, L. H., Hollsberg, P., & Hafler, D. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281608 · Cited by 318
An HTLV-I Vaccine: Why, How, for Whom?
DE THÉ, G., & BOMFORD, R. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.381 · Cited by 272
Landau, N. R., Page, K. A., & Littman, D. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.162-169.1991 · Cited by 271
Retrovirus Envelope Glycoproteins
Hunter, E., & Swanstrom, R. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75218-6_7 · Cited by 262
Manns, A., & Blattner, W. A. (1991) · Transfusion · doi:10.1046/j.1537-2995.1991.31191096189.x · Cited by 174
Kira, J., Koyanagi, Y., Yamada, T., Itoyama, Y., Goto, I., Yamamoto, N., Sasaki, H., & Sakaki, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410290214 · Cited by 152
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Kannian, P., & Green, P. L. (2010) · Viruses · doi:10.3390/v2092037 · Cited by 139
Christensen, A. M., Massiah, M. A., Turner, B. G., Sundquist, W. I., & Summers, M. F. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0700 · Cited by 59
Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
Hoshino, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00222 · Cited by 58
“HTLV-2 is prevalent among intravenous drug users (IDUs) and is endemic among IDUs in the USA, Europe, South America, and Southeast Asia (Lee et al., 1989; Khabbaz et al., 1992; Fukushima et al., 1995).”
Background
Metadata
- Authors
- Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., & Chen, I. S. Y.
- Venue
- Science
- Published
- 1989-04-28
- Volume
- 244
- Issue
- 4903
- Pages
- 471-475
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1993108804
- Cited by
- 424
- References
- 38
- FWCI
- 26.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.